Search Options Stock News and Analysis from Schaeffer's

REGN Finds Redemption After Impressive Earnings Report

https://www.schaeffersresearch.com/content/news/2021/05/06/regn-finds-redemption-after-impressive-earnings-report

5/6/2021 10:40 AM

The shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) are rising on the company's upbeat first-quarter earnings report, which boasted a rise in profits to $9.89 per share -- toppling analysts' es...

Blowout Earnings, Revenue Beat Push Regeneron Stock Higher

https://www.schaeffersresearch.com/content/news/2021/02/05/blowout-earnings-revenue-beat-push-regeneron-stock-higher

2/5/2021 10:22 AM

The shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) are up 2.3% to trade at $510.38 this morning, after the company reported better-than-expected fourth-quarter earnings of $9.53 per share -- s...

Regeneron Stock Boosted on Published Results

https://www.schaeffersresearch.com/content/news/2020/12/18/regeneron-stock-boosted-on-published-results

12/18/2020 12:56 PM

The shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) are up 1.8% at $505.38 at last check. The stock is in the spotlight today after the New England Journal of Medicine published positive initia...

Dow on the Rise to Start Thanksgiving Week

https://www.schaeffersresearch.com/content/ezines/2020/11/23/dow-on-the-rise-to-start-thanksgiving-week

11/23/2020 11:56 AM

The Dow Jones Industrial Average (DJI) is up over 150 points midday, after AstraZeneca (AZN) became the most recent drug stock to boost the market with upbeat vaccine data. The London-based drugma...

REGN Rises on Quarterly Win, Potential COVID-19 Treatment Approval

https://www.schaeffersresearch.com/content/news/2020/11/05/regn-rises-on-quarterly-win-potential-covid-19-treatment-approval

11/5/2020 3:24 PM

The shares of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) are up 0.3% at $588.86 at last check, after the company reported third-quarter earnings of $8.36 per share -- significantly higher than Wall...

PEOPLE ALSO SEARCH FOR